Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. - Wikidata - wikimedia - TriplyDB

Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.

Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.

http://www.wikidata.org/entity/Q37394755

about

Tremelimumab: research and clinical development Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications Pathways and therapeutic targets in melanoma TCRs Used in Cancer Gene Therapy Cross-React with MART-1/Melan-A Tumor Antigens via Distinct Mechanisms Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy.Combination Approaches with Immune-Checkpoint Blockade in Cancer Therapy Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors Therapeutic cancer vaccines and combination immunotherapies involving vaccination Interface of signal transduction inhibition and immunotherapy in melanoma.CTLA4 blockade broadens the peripheral T-cell receptor repertoire Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBM Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis.Redirecting the immune response: role of adoptive T cell therapy.Overview of cellular immunotherapy for patients with glioblastoma.In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells.Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy Targeting CD8+ T-cell tolerance for cancer immunotherapy.Optimizing dendritic cell-based approaches for cancer immunotherapy Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go.CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations Clinical Development of Immune Checkpoint Inhibitors.Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies.Natural killer T cells in advanced melanoma patients treated with tremelimumab Ctla-4 blockade plus adoptive T-cell transfer promotes optimal melanoma immunity in mice Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer.TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.Trial watch: Dendritic cell-based interventions for cancer therapy Biomarkers on melanoma patient T cells associated with ipilimumab treatment.The role of B7 family molecules in hematologic malignancy Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab.CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours.A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells.Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma.

P2860

Q26752822-96CDEE0A-0445-4277-BA13-81F9CA1AF13D Q26772715-2772C661-99AA-4F53-90FC-C7EBE54233B1 Q26779221-814926BC-E209-41CA-945F-413F51A3133F Q26865736-C2AB9B80-0E14-4779-B0E4-2AB5ECBC9332 Q27671024-83ABC8D2-3F30-4531-A2DB-79D3F756698A Q27686800-26D6879E-6529-4032-B17F-DB6B852FF8C6 Q28066199-42300DD7-D85B-4DB8-A71B-C1075D5B8FA1 Q28072532-0BA7FF7B-45AF-4F53-9093-2A22EF950857 Q28397609-7C7F7FA8-8E64-46F5-A288-EBD94E44639F Q30429380-C3D83DDC-F0FC-4862-811B-E90ED2C85BF5 Q33560753-5A7AB08A-5187-4AA2-8238-E33ACC6C799C Q33578030-AC1DBCD5-E9E5-45B4-8A24-816978764BD1 Q33886261-72CB78AF-84AD-4C9D-A6D0-9973C785FBB8 Q34123238-D83DB233-08D1-4EFF-8693-6CE6BADF8B40 Q34189694-8C1A1366-7EBF-49C4-9EB8-1E95275A58C6 Q34194680-EAC12BAE-81FE-4C6D-A8AF-C9F922B20426 Q34198563-EAE016E5-AA29-447F-8B2A-7ACE5A7FA2F3 Q34329143-E0790869-E121-4522-904A-6D5D59ECD65B Q34334598-61FB9426-2B60-4F02-B58B-9A337285FE11 Q34432692-BD07F0E5-76CE-413A-AC6E-B1FA55FE6DBB Q34637535-80644D59-43D9-44E4-AFF0-C3E5ADC2CF9B Q34658452-F28124A1-5BBC-4098-9918-35A6BFBA3FE8 Q34667662-062B3B0B-1384-453E-B31C-14E6C0A1D1F3 Q34671498-066C3E0B-A202-4822-AC7D-7989B0A2D79A Q34898280-A829767D-29DC-41BB-8246-C8E1D3A0A148 Q35027661-806061B4-473F-4620-8503-02012470A6DD Q35064059-B8325A15-B66F-4D42-9ED3-91F588FA6079 Q35235365-B2671A14-56B5-463D-98A6-432130921594 Q35250795-0E922E7B-83E2-4860-95DF-C9B17C931A86 Q35669197-1116AA8E-AB27-4F0D-A525-BDDE944D5287 Q35886767-5BAB7DE0-41E2-4C42-98B9-B3C3DD4BBCEE Q36057454-BFBA2A7C-3230-4A3A-82AB-50C476ED6733 Q36388529-84483742-B7A5-4E5B-B631-96CB3641B9CC Q36480617-A734FE26-4031-413C-81BB-EA63873E1745 Q36584814-8FF3095B-2363-4181-91C3-CC7D496B9FF1 Q36765800-6527C3BE-FF88-4772-BFF4-E3B3DAB295FA Q36846646-C5E8925A-931D-42DE-B8A8-7BF1C42D020F Q36896203-B87CEDE8-2DB9-4265-ADB1-8B75299F5522 Q36926465-05E2C17D-CD13-4BAB-8B7A-09667D2CFA12 Q37014061-5146E5AE-7DDA-458C-8337-03550E64B129

P2860

Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.

http://www.wikidata.org/entity/Q37394755

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dendritic cell vaccination com ...... ents with metastatic melanoma.

@en

Dendritic cell vaccination com ...... ents with metastatic melanoma.

@nl

type

label

Dendritic cell vaccination com ...... ents with metastatic melanoma.

@en

Dendritic cell vaccination com ...... ents with metastatic melanoma.

@nl

prefLabel

Dendritic cell vaccination com ...... ents with metastatic melanoma.

@en

Dendritic cell vaccination com ...... ents with metastatic melanoma.

@nl

P1433

Q37394755-F363F6B6-CDA0-4A88-9C79-1C6A7BDA3778

P1476

Q37394755-1CD46067-CFCA-44A8-90A0-B2E60DF065D6

P2093

Q37394755-30BF7544-F751-427D-8BE8-121C68D7E63E

Q37394755-332692A4-04BF-4D6D-BFD2-431AFFC64477

Q37394755-36E54938-994D-45CC-AA2D-7CF9CB0C70A9

Q37394755-3B115FF0-DFA3-4903-AD0D-871EB582FBA6

Q37394755-54614388-ABF2-4B92-9EA8-52B18AC1FD0D

Q37394755-5BA4391A-A036-40C5-AD78-FCC96C2B899E

Q37394755-6361B709-EAAD-469A-BDAD-B61B4551F330

Q37394755-6652F8D3-18DC-4083-8BF6-586ACA42FAE8

Q37394755-790C43EF-3BE8-4A16-9242-B44BE73F36CF

Q37394755-7CCBF43D-5687-4A42-91BF-EBAD565E2B1F

P2860

Q37394755-0740E675-4B6F-4E8E-8E95-16E46F84C2DE

Q37394755-0AF8B94C-776D-49F1-92F1-A3A6AB1CFFD5

Q37394755-0D0FCBD1-5DA4-4920-8C24-EF02E4EAE667

Q37394755-13A89A7D-24F9-4676-8CF5-2CC0DB2F7D34

Q37394755-153FF5E0-E360-4758-9DBE-7A9E4A8115AA

Q37394755-16944381-C92D-4A59-80BB-1CB116FE592E

Q37394755-2056D370-87B5-4D00-9F62-7B133A0F0704

Q37394755-2CCB7262-277A-4B41-8E98-8781458FB2DD

Q37394755-2EC423DE-AE95-49C9-B9EF-31430D1F26B3

Q37394755-3049F471-BDCE-463E-8C06-E7CEEC8CC850

P304

Q37394755-BC14C9C5-CAA2-402F-AAEA-B34AE486E47A

P31

Q37394755-3DA8861B-92A7-4720-A916-8E04911AFD19

P356

Q37394755-9A408607-BAF5-47EE-8411-DD724A325144

P407

Q37394755-8174B9CD-6B57-488B-8989-AB2F52525928

P433

Q37394755-FCB03439-94C2-48D7-A7BF-E319D0E18802

P478

Q37394755-49FAA87B-5F83-477D-8E1D-F1196FE01144

P50

Q37394755-67170666-AE25-44CE-884F-E6AAB1F63E56

Q37394755-DC6B7EA3-F357-47E1-A8F4-86331DADF115

Q37394755-DFBA44F7-139A-4E3B-A648-C453F8779FCC

P577

Q37394755-56D21310-723D-4363-A561-96841DB6B7FF

P5875

Q37394755-59392B1E-991E-4CD4-9D45-367A711D2348

P698

Q37394755-1FEAD697-B9FB-4D95-9A8A-E4D83D2D1A02

P921

Q37394755-A8010A7A-3FF7-400D-8E90-AB1A772C435E

P932

Q37394755-15B13124-4C23-4C11-B347-C0E3194F4EA7

P356

1078-0432.CCR-09-1254

P1433

Clinical Cancer Research

P1476

Dendritic cell vaccination com ...... ents with metastatic melanoma.

@en

P2093

Alistair J Cochran

http://www.w3.org/2001/XMLSchema#string

Arturo Villanueva

http://www.w3.org/2001/XMLSchema#string

Bradley R Straatsma

http://www.w3.org/2001/XMLSchema#string

Denise K Oseguera

http://www.w3.org/2001/XMLSchema#string

Elizabeth Seja

http://www.w3.org/2001/XMLSchema#string

Ena Wang

http://www.w3.org/2001/XMLSchema#string

Francesco M Marincola

http://www.w3.org/2001/XMLSchema#string

James S Economou

http://www.w3.org/2001/XMLSchema#string

Jason Jalil

http://www.w3.org/2001/XMLSchema#string

Jesus Gomez-Navarro

http://www.w3.org/2001/XMLSchema#string

P2860

Cluster analysis and display of genome-wide expression patterns

Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration

Selection and validation of endogenous reference genes using a high throughput approach

RNA amplification for successful gene profiling analysis.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Reversal of the TCR stop signal by CTLA-4

Enhancement of antitumor immunity by CTLA-4 blockade

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".

Analysis of gene expression data using BRB-ArrayTools.

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.

P304

6267-6276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-09-1254

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Bartosz Chmielowski

Begoña Comin-Anduix

P577

2009-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26856143

http://www.w3.org/2001/XMLSchema#string

P698

19789309

http://www.w3.org/2001/XMLSchema#string

P921

P932

2765061

http://www.w3.org/2001/XMLSchema#string